688656 浩欧博
已收盘 08-24 15:00:01
资讯
新帖
简况
每周股票复盘：浩欧博（688656）Q2净利同比增56.7%
证券之星 · 08-23 03:58
每周股票复盘：浩欧博（688656）Q2净利同比增56.7%
股市必读：浩欧博中报 - 第二季度单季净利润同比增长56.70%
证券之星 · 08-19
股市必读：浩欧博中报 - 第二季度单季净利润同比增长56.70%
浩欧博(688656)6月30日股东户数0.35万户，较上期减少2.31%
证券之星 · 08-18
浩欧博(688656)6月30日股东户数0.35万户，较上期减少2.31%
股市必读：浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》
证券之星 · 08-18
股市必读：浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》
图解浩欧博中报：第二季度单季净利润同比增长56.70%
证券之星 · 08-18
图解浩欧博中报：第二季度单季净利润同比增长56.70%
浩欧博(688656.SH)发布半年度业绩，归母净利润1667.76万元，同比增长37.05%
智通财经 · 08-17
浩欧博(688656.SH)发布半年度业绩，归母净利润1667.76万元，同比增长37.05%
每周股票复盘：浩欧博（688656）子公司获7项医疗器械注册证
证券之星 · 07-19
每周股票复盘：浩欧博（688656）子公司获7项医疗器械注册证
7月17日浩欧博跌14.24%，嘉实稳福混合A基金重仓该股
证券之星 · 07-17
7月17日浩欧博跌14.24%，嘉实稳福混合A基金重仓该股
浩欧博最新公告：全资子公司获7项医疗器械注册证
证券之星 · 07-15
浩欧博最新公告：全资子公司获7项医疗器械注册证
7月13日浩欧博跌5.33%，嘉实稳福混合A基金重仓该股
证券之星 · 07-13
7月13日浩欧博跌5.33%，嘉实稳福混合A基金重仓该股
7月10日浩欧博涨5.18%，嘉实稳福混合A基金重仓该股
证券之星 · 07-10
7月10日浩欧博涨5.18%，嘉实稳福混合A基金重仓该股
每周股票复盘：浩欧博（688656）完成董事会换届及高管聘任
证券之星 · 07-05
每周股票复盘：浩欧博（688656）完成董事会换届及高管聘任
浩欧博（688656）披露董事会换届选举结果，7月3日股价下跌0.49%
证券之星 · 07-03
浩欧博（688656）披露董事会换届选举结果，7月3日股价下跌0.49%
浩欧博（688656）披露董事会换届选举议案，6月24日股价下跌1.4%
证券之星 · 06-24
浩欧博（688656）披露董事会换届选举议案，6月24日股价下跌1.4%
浩欧博（688656）披露2023年限制性股票激励计划首次授予部分第一个归属期归属结果暨股票上市公告，6月23日股价下跌3.36%
证券之星 · 06-23
浩欧博（688656）披露2023年限制性股票激励计划首次授予部分第一个归属期归属结果暨股票上市公告，6月23日股价下跌3.36%
浩欧博（688656）披露召开2026年第二次临时股东会的通知，6月17日股价下跌3.14%
证券之星 · 06-17
浩欧博（688656）披露召开2026年第二次临时股东会的通知，6月17日股价下跌3.14%
6月8日浩欧博跌5.72%，嘉实稳福混合A基金重仓该股
证券之星 · 06-08
6月8日浩欧博跌5.72%，嘉实稳福混合A基金重仓该股
股市必读：浩欧博（688656）今年截至5月28日累计跌幅已超25%
证券之星 · 05-29
股市必读：浩欧博（688656）今年截至5月28日累计跌幅已超25%
每周股票复盘：浩欧博（688656）5月19日发生379.7万元大宗交易
证券之星 · 05-24
每周股票复盘：浩欧博（688656）5月19日发生379.7万元大宗交易
浩欧博（688656）披露2025年年度权益分派实施公告，5月22日股价上涨0.27%
证券之星 · 05-22
浩欧博（688656）披露2025年年度权益分派实施公告，5月22日股价上涨0.27%
公司概况
公司名称：
江苏浩欧博生物医药股份有限公司
所属行业：
医药制造业
上市日期：
2021-01-13
主营业务：
江苏浩欧博生物医药股份有限公司的主营业务是体外诊断试剂的研发、生产和销售。公司的主要产品是IgE检测、食物特异性IgG检测、自身免疫性疾病检测。
发行价格：
35.26
{"stockData":{"symbol":"688656","market":"SH","secType":"STK","nameCN":"浩欧博","latestPrice":94.88,"timestamp":1787554801000,"preClose":101.78,"halted":0,"volume":1572068,"delay":0,"changeRate":-0.0678,"floatShares":63518600,"shares":63518600,"eps":0.4363,"marketStatus":"已收盘","change":-6.9,"latestTime":"08-24 15:00:01","open":103.43,"high":103.43,"low":91.65,"amount":148000000,"amplitude":0.1157,"askPrice":94.88,"askSize":36,"bidPrice":94.75,"bidSize":11,"shortable":0,"etf":0,"ttmEps":0.4363,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"adjPreClose":101.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1787535000000,1787542200000],[1787547600000,1787554800000]],"highLimit":111.96,"lowLimit":91.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":63518621,"isCdr":false,"pbRate":7.25,"roa":"--","peRate":217.465047,"roe":"2.01%","epsLYR":0.37,"committee":-0.061224,"marketValue":6027000000,"turnoverRate":0.0247,"status":1,"afterMarket":{"amount":0,"volume":0,"close":94.88,"buyVolume":1554,"sellVolume":0,"time":1787556837746,"indexStatus":"已收盘 08-24 15:30:00","preClose":101.78},"floatMarketCap":6027000000},"requestUrl":"/m/hq/s/688656/wiki","defaultTab":"wiki","newsList":[{"id":"2661214671","title":"每周股票复盘：浩欧博（688656）Q2净利同比增56.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661214671","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661214671?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:58","pubTimestamp":1787428712,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，浩欧博报收于101.78元，较上周的93.15元上涨9.26%。业绩披露要点浩欧博2026年中报显示，上半年主营收入1.96亿元，同比上升3.22%；归母净利润1667.76万元，同比上升37.05%；扣非净利润1533.08万元，同比上升47.99%。江苏浩欧博生物医药股份有限公司将于2026年8月27日15:00-16:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660159499","title":"股市必读：浩欧博中报 - 第二季度单季净利润同比增长56.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660159499","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660159499?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:29","pubTimestamp":1787074147,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年6月30日股东户数为3509.0户，较3月31日减少2.31%，户均持股增至1.81万股。业绩披露要点财务报告2026年中报显示：主营收入1.96亿元，同比上升3.22%；归母净利润1667.76万元，同比上升37.05%；扣非净利润1533.08万元，同比上升47.99%。其中第二季度单季度主营收入1.17亿元，同比上升4.33%；归母净利润1650.01万元，同比上升56.7%；扣非净利润1592.34万元，同比上升57.37%；负债率9.29%，财务费用104.19万元，毛利率60.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465969","title":"浩欧博(688656)6月30日股东户数0.35万户，较上期减少2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465969","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465969?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:27","pubTimestamp":1787045270,"startTime":"0","endTime":"0","summary":"证券之星消息，近日浩欧博披露，截至2026年6月30日公司股东户数为3509.0户，较3月31日减少83.0户，减幅为2.31%。在医疗器械行业个股中，浩欧博股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2026年3月31日至2026年6月30日，浩欧博区间跌幅为20.27%，在此期间股东户数减少83.0户，减幅为2.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660943163","title":"股市必读：浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660943163","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660943163?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:34","pubTimestamp":1786988088,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏浩欧博生物医药股份有限公司2026年半年度报告摘要截至报告期末，公司总资产为91,643.41万元，归属于上市公司股东的净资产为83,125.23万元。江苏浩欧博生物医药股份有限公司2026年度“提质增效重回报”专项行动方案的半年度评估报告2026年上半年，公司实现营业收入19,576.93万元，同比增长3.22%；归母净利润1,667.76万元，同比增长37.05%，剔除股份支付因素后净利润同比增长16.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239","161726","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543909","title":"图解浩欧博中报：第二季度单季净利润同比增长56.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660543909?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:13","pubTimestamp":1786986795,"startTime":"0","endTime":"0","summary":"证券之星消息，浩欧博2026年中报显示，上半年度公司主营收入1.96亿元，同比上升3.22%；归母净利润1667.76万元，同比上升37.05%；扣非净利润1533.08万元，同比上升47.99%；其中2026年第二季度，公司单季度主营收入1.17亿元，同比上升4.33%；单季度归母净利润1650.01万元，同比上升56.7%；单季度扣非净利润1592.34万元，同比上升57.37%；负债率9.29%，财务费用104.19万元，毛利率60.34%。财报数据概要请见下图:本文数据来源于浩欧博2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487125","title":"浩欧博(688656.SH)发布半年度业绩，归母净利润1667.76万元，同比增长37.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487125","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660487125?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:20","pubTimestamp":1786969212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)披露2026年半年度报告，报告期公司实现营业收入1.96亿元，同比增长3.22%;归属于上市公司股东的净利润1667.76万元，同比增长37.05%;归属于上市公司股东的扣除非经常性损益的净利润1533.08万元，同比增长47.99%;基本每股收益0.27元。公司持续深耕海南自贸港、粤港澳大湾区“药械通”政策落地区域，加大脱敏药欧脱克市场推广投入，带动脱敏药板块收入增长116.83%;诊断检测业务海外市场拓展成效显著，境外销售收入同比提升38.11%;国内诊断业务承压，营业收入微降0.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"浩欧博(688656.SH)发布半年度业绩，归母净利润1667.76万元，同比增长37.05%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230620","title":"每周股票复盘：浩欧博（688656）子公司获7项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230620","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230620?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:38","pubTimestamp":1784399890,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，浩欧博报收于81.51元，较上周的96.72元下跌15.73%。本周，浩欧博7月16日盘中最高价报99.85元。浩欧博当前最新总市值51.77亿元，在医疗器械板块市值排名62/129，在两市A股市值排名2884/5199。本周关注点公司公告汇总：全资子公司湖南浩欧博获7项医疗器械注册证，涉及多种过敏原检测试剂盒。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","688656","09996","BK1574","159883","BK0239","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652817406","title":"7月17日浩欧博跌14.24%，嘉实稳福混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652817406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652817406?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:34","pubTimestamp":1784277261,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日浩欧博跌14.24%创60日新低，收盘报81.51元，换手率1.69%，成交量1.08万手，成交额9320.05万元。嘉实稳福混合A目前规模为1.27亿元，最新净值1.2525，较上一交易日下跌0.38%，近一年上涨2.41%。嘉实稳福混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454578","title":"浩欧博最新公告：全资子公司获7项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454578","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651454578?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:11","pubTimestamp":1784110291,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)公告称，公司全资子公司湖南浩欧博生物医药有限公司近日获得7项由湖南省药品监督管理局核准签发的医疗器械注册证，包括过敏原特异性IgE抗体检测试剂盒(坚果混合FX28、霉菌混合MX14、树木混合TX1、海鲜混合FX3、水果混合FX30、草混合WX1)及热带无爪螨过敏原特异性IgE抗体测定试剂盒。上述产品均采用磁微粒化学发光法，用于过敏症的辅助诊断。此次获证丰富了公司化学发光平台检测菜单，有助于提升市场竞争力，但实际销售情况取决于未来市场拓展效果。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500037349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1583","688656","159883","BK1574","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019474","title":"7月13日浩欧博跌5.33%，嘉实稳福混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651019474?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:36","pubTimestamp":1783931775,"startTime":"0","endTime":"0","summary":"证券之星消息，7月13日浩欧博跌5.33%，收盘报91.56元，换手率0.93%，成交量5878.0手，成交额5474.69万元。重仓浩欧博的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为嘉实基金的嘉实稳福混合A。嘉实稳福混合A目前规模为1.27亿元，最新净值1.2625，较上一交易日下跌0.17%，近一年上涨3.3%。嘉实稳福混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300023409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650183941","title":"7月10日浩欧博涨5.18%，嘉实稳福混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650183941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650183941?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:26","pubTimestamp":1783671993,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日浩欧博涨5.18%创60日新低，收盘报96.72元，换手率1.13%，成交量7151.0手，成交额6896.73万元。重仓浩欧博的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为嘉实基金的嘉实稳福混合A。嘉实稳福混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000028963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649921266","title":"每周股票复盘：浩欧博（688656）完成董事会换届及高管聘任","url":"https://stock-news.laohu8.com/highlight/detail?id=2649921266","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649921266?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:10","pubTimestamp":1783195823,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，浩欧博报收于103.55元，较上周的98.0元上涨5.66%。本周关注点公司公告汇总：浩欧博完成董事会换届，选举JOHN LI为董事长并聘任其为总经理。公司公告汇总江苏浩欧博生物医药股份有限公司于2026年7月3日召开2026年第二次临时股东会，审议通过董事会换届选举议案。任期均至第四届董事会任期届满。本次修订经董事会审议通过，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648664879","title":"浩欧博（688656）披露董事会换届选举结果，7月3日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648664879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648664879?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:54","pubTimestamp":1783090459,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，浩欧博报收于103.55元，较前一交易日下跌0.49%，最新总市值为65.77亿元。该股当日开盘105.45元，最高107.21元，最低101.77元，成交额达7793.49万元，换手率为1.18%。近日，江苏浩欧博生物医药股份有限公司披露2026年第二次临时股东会决议公告。公司于2026年7月3日召开2026年第二次临时股东会，审议通过董事会换届选举议案。所有候选人得票率均超过出席会议有效表决权的99%，全部当选。出席会议的股东所持表决权占公司总表决权的69.4953%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300046117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645811958","title":"浩欧博（688656）披露董事会换届选举议案，6月24日股价下跌1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645811958","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645811958?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:51","pubTimestamp":1782312675,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，浩欧博报收于97.19元，较前一交易日下跌1.4%，最新总市值为61.73亿元。该股当日开盘97.83元，最高100.5元，最低96.5元，成交额达3978.88万元，换手率为0.64%。近日，江苏浩欧博生物医药股份有限公司披露《2026年第二次临时股东会会议资料》，公司将于2026年7月3日召开2026年第二次临时股东会，审议董事会换届选举相关议案。本次会议采取现场投票与网络投票相结合的方式进行表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400044358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645832705","title":"浩欧博（688656）披露2023年限制性股票激励计划首次授予部分第一个归属期归属结果暨股票上市公告，6月23日股价下跌3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645832705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645832705?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:28","pubTimestamp":1782224898,"startTime":"0","endTime":"0","summary":"近日，江苏浩欧博生物医药股份有限公司发布《2023年限制性股票激励计划首次授予部分第一类激励对象第一个归属期归属结果暨股票上市公告》。公告显示，公司已完成2023年限制性股票激励计划首次授予部分第一类激励对象第一个归属期的股份归属登记，共向5名激励对象归属38,881股，股票来源为公司向激励对象定向发行A股普通股，上市流通日期为2026年6月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742019","title":"浩欧博（688656）披露召开2026年第二次临时股东会的通知，6月17日股价下跌3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644742019?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:55","pubTimestamp":1781708114,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，浩欧博报收于104.58元，较前一交易日下跌3.14%，最新总市值为66.39亿元。该股当日开盘108.02元，最高108.04元，最低103.58元，成交额达7551.5万元，换手率为1.13%。近日，江苏浩欧博生物医药股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年7月3日召开2026年第二次临时股东会，会议采取现场投票与网络投票相结合的方式，股权登记日为2026年6月29日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641071781","title":"6月8日浩欧博跌5.72%，嘉实稳福混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641071781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641071781?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:47","pubTimestamp":1780908444,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日浩欧博跌5.72%，收盘报97.5元，换手率1.02%，成交量6487.0手，成交额6420.43万元。重仓浩欧博的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为嘉实基金的嘉实稳福混合A。嘉实稳福混合A目前规模为1.27亿元，最新净值1.2584，较上一交易日下跌0.18%，近一年上涨3.99%。嘉实稳福混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639615633","title":"股市必读：浩欧博（688656）今年截至5月28日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639615633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639615633?lang=zh_cn&edition=full","pubTime":"2026-05-29 03:39","pubTimestamp":1779997151,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，浩欧博报收于112.3元，下跌1.02%，换手率0.44%，成交量2791.0手，成交额3160.69万元。当日关注点来自交易信息汇总：浩欧博股价已连续10日下跌，年内累计跌幅达26.94%。来自资金流向：5月28日主力资金净流入39.96万元，占总成交额1.26%。交易信息汇总股价提醒5月28日浩欧博收盘报112.3元，跌1.02%，当日成交27.91万元。前10个交易日中，主力资金累计净流出1191.15万元，股价累计下跌14.55%；融资余额累计减少1784.93万元，融券余量累计增加0股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900004833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637260376","title":"每周股票复盘：浩欧博（688656）5月19日发生379.7万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2637260376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637260376?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:14","pubTimestamp":1779570853,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，浩欧博报收于125.0元，较上周的135.72元下跌7.9%。本周，浩欧博5月18日盘中最高价报137.1元。交易信息汇总5月19日浩欧博发生1笔大宗交易，成交金额379.7万元。公司公告汇总江苏浩欧博生物医药股份有限公司2025年年度权益分派实施公告：每股派发现金红利0.20元（含税），股权登记日为2026年5月28日，除权（息）日为2026年5月29日，现金红利发放日为2026年5月29日。截至2026年5月11日，参与分配的股本为62,678,426股，总股本63,479,740股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637348990","title":"浩欧博（688656）披露2025年年度权益分派实施公告，5月22日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637348990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637348990?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:43","pubTimestamp":1779460993,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，浩欧博报收于125.0元，较前一交易日上涨0.27%，最新总市值为79.35亿元。该股当日开盘125.0元，最高126.89元，最低123.86元，成交额达4656.38万元，换手率为0.59%。近日，江苏浩欧博生物医药股份有限公司发布《2025年年度权益分派实施公告》：每股派发现金红利0.20元（含税），股权登记日为2026年5月28日，除权（息）日为2026年5月29日，现金红利发放日为2026年5月29日。公司回购专用账户股份不参与分配。差异化分红导致除权参考价调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787579060993,"stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":0.2328},{"period":"3month","weight":-0.1843},{"period":"6month","weight":-0.3092},{"period":"1year","weight":-0.1883},{"period":"ytd","weight":-0.337}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏浩欧博生物医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"3509人(较上一季度减少2.31%)","perCapita":"18101股","listingDate":"2021-01-13","address":"江苏省苏州市虎丘区中国(江苏)自由贸易试验区苏州片区苏州工业园区东堰里路9号","registeredCapital":"6351万元","survey":" 江苏浩欧博生物医药股份有限公司的主营业务是体外诊断试剂的研发、生产和销售。公司的主要产品是IgE检测、食物特异性IgG检测、自身免疫性疾病检测。","listedPrice":35.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浩欧博,688656,浩欧博股票,浩欧博股票老虎,浩欧博股票老虎国际,浩欧博行情,浩欧博股票行情,浩欧博股价,浩欧博股市,浩欧博股票价格,浩欧博股票交易,浩欧博股票购买,浩欧博股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}